HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[FGF23 in chronic kidney disease and kidney post-transplant patients].

Abstract
Phosphatonins are regulatory factors of phosphate metabolism and the FGF23 is the best studied of them. This has produced a change in our understanding in mineral metabolism and specifically of phosphate regulation. FGF23 is a 251-amino acid factor that differs from other FGF family members by having a 71-amino acid extension on the carboxyl-terminal end of the molecule that is specific for this factor. It is primarily produced by osteocytes in bone. It has a central role in phosphate homeostasis regulation, producing phosphaturia, and in vitamin D metabolism, inhibiting its production by suppression of renal 1 Alfa hydroxylase. It is believed to have an important place in the pathogenesis of early secondary hyperparathiroidism related to chronic renal insufficiency by inhibiting renal synthesis of 1,25(OH)2D in response to its increment in blood produced to increase renal phosphate excretion and maintain phosphate balance. In CRF its serum levels seem to be independent predictors of progression to terminal renal failure. In dialysis patients the determination of its serum levels would allow to predict the results of therapy with calcitriol in the treatment of secondary hyperparathyroidism; they also seem to be independent predictors of the risk of mortality during the first year of hemodialysis. Its serum levels have also been related to the development of vascular calcifications of hand arteries but not with aortic calcifications. The exposure to excessive levels of FGF23 in the early postransplant period seems to be strongly associated with postransplant hypophophatemia more than to PTH or other phosphatonins.
AuthorsAl Negri
JournalNefrologia : publicacion oficial de la Sociedad Espanola Nefrologia (Nefrologia) Vol. 29 Issue 3 Pg. 196-202 ( 2009) ISSN: 0211-6995 [Print] Spain
Vernacular TitleEl FGF23 en la insuficiencia renal crónica y el postrasplante renal.
PMID19554051 (Publication Type: Journal Article, Review)
Chemical References
  • FGF23 protein, human
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
Topics
  • Chronic Disease
  • Disease Progression
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors (blood, physiology)
  • Humans
  • Kidney Diseases (blood, etiology)
  • Kidney Transplantation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: